Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma.

阅读:7
作者:Li Chenguang, Gao Zhibo, Li Fei, Li Xiangchun, Sun Yihua, Wang Mengyun, Li Dan, Wang Rui, Li Fuming, Fang Rong, Pan Yunjian, Luo Xiaoyang, He Jing, Zheng Liangtao, Xia Jufeng, Qiu Lixin, He Jun, Ye Ting, Zhang Ruoxin, He Minghui, Zhu Meiling, Hu Haichuan, Shi Tingyan, Zhou Xiaoyan, Sun Menghong, Tian Shilin, Zhou Yong, Wang Qiaoxiu, Chen Longyun, Yin Guangliang, Lu Jingya, Wu Renhua, Guo Guangwu, Li Yingrui, Hu Xueda, Li Lin, Asan, Wang Qin, Yin Ye, Feng Qiang, Wang Bin, Wang Hang, Wang Mingbang, Yang Xiaonan, Zhang Xiuqing, Yang Huanming, Jin Li, Wang Cun-Yu, Ji Hongbin, Chen Haiquan, Wang Jun, Wei Qingyi
Lung squamous cell carcinoma (SQCC) accounts for about 30% of all lung cancer cases. Understanding of mutational landscape for this subtype of lung cancer in Chinese patients is currently limited. We performed whole exome sequencing in samples from 100 patients with lung SQCCs to search for somatic mutations and the subsequent target capture sequencing in another 98 samples for validation. We identified 20 significantly mutated genes, including TP53, CDH10, NFE2L2 and PTEN. Pathways with frequently mutated genes included those of cell-cell adhesion/Wnt/Hippo in 76%, oxidative stress response in 21%, and phosphatidylinositol-3-OH kinase in 36% of the tested tumor samples. Mutations of Chromatin regulatory factor genes were identified at a lower frequency. In functional assays, we observed that knockdown of CDH10 promoted cell proliferation, soft-agar colony formation, cell migration and cell invasion, and overexpression of CDH10 inhibited cell proliferation. This mutational landscape of lung SQCC in Chinese patients improves our current understanding of lung carcinogenesis, early diagnosis and personalized therapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。